CB-13
From Infogalactic: the planetary knowledge core
Systematic (IUPAC) name | |
---|---|
naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone
|
|
Clinical data | |
Legal status |
|
Identifiers | |
CAS Number | 432047-72-8 |
PubChem | CID: 9799417 |
ChemSpider | 7975182 |
ChEMBL | CHEMBL244403 |
Chemical data | |
Formula | C26H24O2 |
Molecular mass | 368.467 g/mol |
|
|
|
|
(verify) |
CB-13 (CRA13, SAB-378)[1] is a cannabinoid drug, which acts as a potent agonist at both the CB1 and CB2 receptors, but has poor blood–brain barrier penetration, and so produces only peripheral effects at low doses, with symptoms of central effects such as catalepsy only appearing at much higher dose ranges. It has antihyperalgesic properties in animal studies,[2] and has progressed to preliminary human trials.[3]
Legal Status
As of October 2015 CB-13 is a controlled substance in China.[4]
See also
References
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
<templatestyles src="Asbox/styles.css"></templatestyles>
Categories:
- Chemical articles having calculated molecular weight overwritten
- Infobox drug articles without a structure image
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without UNII source
- Drugboxes with an unspecified ATC code
- Cannabinoids
- Designer drugs
- Naphthalenes
- Aromatic ketones
- Naphthol ethers
- Peripherally selective drugs
- Cannabinoid stubs